2022, May 25 – Free Clinician’s Brief Webinar
May 25 @ 5:00 pm - 6:00 pm PDTFREE
The Future of Cancer Detection is Here: Revolutionize Cancer Detection with Liquid Biopsy
New cutting-edge technology is helping general practitioners detect more than 30 types of cancer with a single blood draw. Join us in this webinar to see how you, your practice, and your patients could benefit from liquid biopsy testing.
Cancer is the leading cause of death in dogs, likely due in part to delays in diagnosis, and traditional testing often requires specialized and invasive techniques. Register for this webinar to meet the new technology that’s here to change the way canine cancer is detected with a single blood draw. Whether screening for cancer at wellness visits or an aid in diagnosis for a sick pet, this new technology is here to help veterinarians detect cancer earlier.
Angela McCleary-Wheeler, DVM, PhD, DACVIM (Oncology)
What You’ll Learn
- Define “liquid biopsy” and examine how next-generation sequencing can be used to identify cancer-associated genomic alterations in the blood of dogs
- Review test performance metrics such as sensitivity and specificity and determine positive and negative predictive values to better understand your patient’s liquid biopsy results
- Identify real-world opportunities for liquid biopsy incorporation into routine wellness examinations or as an aid in diagnosis when cancer is on the differential diagnoses list
If you are unable to make this date and time, please submit a registration anyway. A RACE-approved online course will be created using the archived recording of the webinar. All who register for the webinar will be able to access links once the course is open to enrollment.
This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval.
Acknowledgment of Commercial Support
This webinar is sponsored by PetDx.